This trial is testing whether a new type of radiation therapy can help cancer patients by limiting side effects and improve disease control.
1 Primary · 5 Secondary · Reporting Duration: Baseline to study end (up to 5 years)
55 Total Participants · 1 Treatment Group
Primary Treatment: Evidence-based radiation dose limitation to the vertebral bone marrow · No Placebo Group · N/A
Age 18+ · All Participants · 8 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: